Transcriptomic and functional pathway features were associated with survival after pathological complete response to neoadjuvant chemotherapy in breast cancer.

Takeshita, Takashi; Yan, Li; Peng, Xuan; Kimbung, Siker; Hatschek, Thomas; Hedenfalk, Ingrid A; Rashid, Omar M; Takabe, Kazuaki

Takeshita, Takashi; Yan, Li; Peng, Xuan; Kimbung, Siker; Hatschek, Thomas; Hedenfalk, Ingrid A; Rashid, Omar M; Takabe, Kazuaki.

Afiliación

Takeshita T; Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center Buffalo, NY, USA.
Yan L; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center Buffalo, NY, USA.
Peng X; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center Buffalo, NY, USA.
Kimbung S; Division of Oncology, Department of Clinical Sciences and Lund University Cancer Center, Lund University Lund, Sweden.
Hatschek T; Breast Center, Karolinska University Hospital and Department of Oncology-Pathology, Karolinska Institutet Solna, Sweden.
Hedenfalk IA; Division of Oncology, Department of Clinical Sciences and Lund University Cancer Center, Lund University Lund, Sweden.
Rashid OM; Holy Cross Hospital Michael and Dianne Bienes Comprehensive Cancer Center Fort Lauderdale, Florida, USA.
Takabe K; Department of Surgery, Massachusetts General Hospital Boston, Massachusetts, USA.

Am J Cancer Res ; 10(8): 2555-2569, 2020.

Article en En | MEDLINE | ID: mdl-32905537

Palabras clave

Breast cancer; bioinformatics; cancer genomics; functional pathway; pCR and survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google